Evofem Biosciences, Inc.
EVFM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,860 | $52,979 | -$76,698 | -$205,192 |
| Dep. & Amort. | $756 | $1,781 | $2,046 | $1,023 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $847 | $1,189 | $3,313 | $8,898 |
| Change in WC | $867 | $4,728 | $6,018 | $10,578 |
| Other Non-Cash | $2,505 | -$69,645 | -$5,089 | $38,026 |
| Operating Cash Flow | -$3,885 | -$8,968 | -$70,410 | -$146,667 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$14 | -$4 | -$341 | -$2,939 |
| Net Acquisitions | -$555 | $0 | $0 | $250 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$569 | -$4 | -$341 | -$2,689 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$385 | $4,486 | $5,608 | $0 |
| Stock Issued | $5,000 | $0 | $32,320 | $81,534 |
| Stock Repurch. | $0 | $0 | -$18 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $290 | $24,029 | -$841 |
| Financing Cash Flow | $4,615 | $4,776 | $61,939 | $90,693 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $161 | -$4,196 | -$8,812 | -$58,663 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $580 | $4,776 | $13,588 | $72,251 |
| End Cash | $741 | $580 | $4,776 | $13,588 |
| Free Cash Flow | -$3,899 | -$8,972 | -$70,751 | -$149,606 |